High Vista Strategies LLC Mannkind Corp Transaction History

High Vista Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.89 - $5.48 $89,781 - $126,478	-23,080 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.45 $83,318 - $125,786	23,080 New	23,080 $126,000
Q3 2020 Nov 16, 2020	SELL	$1.56 - $2.08 $75,816 - $101,088	-48,600 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.04 - $1.44 $50,544 - $69,984	48,600 New	48,600 $61,000

244

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.73B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.